Epidemiology of Leukemia and Multiple Myeloma in Golestan, Iran

Rajabli, Niloofar; Naeimi-Tabeie, Mohammad; Jahangirrad, Ataollah; Sedaghat, Seyed Mehdi; Semnani, Shahryar; Roshandel, Gholamreza

doi:10.7314/apjcp.2013.14.4.2333

Cited by 33 publications

(36 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Overall incidence ratio of leukemia in male to female was 1.13:1. The gender distribution pattern of leukemia in Kazakhstan was in line with those found in other studies (Rajabli et al, 2013;Peter et al, 2013;Novak et al, 2012;Thygesen et al, 2009). It may be proposed that gender has the possible impact on the incidence of leukemia and men are at higher risk of leukemia due to genetic or environmental factors (Peter et al, 2013).…”

Section: Discussionsupporting

confidence: 80%

“…The ASRs of leukemia worldwide were 5.8 in men and 4.3 in women per 100,000 inhabitants (Rajabli et al, 2013). The highest rates for men have been registered in such countries as New Zealand (14.3), Israel (13.4), USA (12.1), Australia (11.9), for women in New Zealand (9.8), Italy (8.6), French Polynesia (8.3), Israel (8.1).…”

Section: Introductionmentioning

confidence: 99%

“…Today cancer is an eminent health problem (Xie et al, 2012), which is responsible for a leading cause of death in developed countries and a second leading cause of death in developing countries (Jemal et al, 2011;Siegel et al, 2012). About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 (Rajabli et al, 2013). According to Globocan 2008, the age-standardized incidence rates (ASR) of all cancers were 202.8 in men and 164.4 in women per 100,000 population.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012

Igissinov

Kulmirzayeva²,

Moore³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Cancer is a major health problem facing the entire world, and Kazakhstan is not the exception. The aim of this study was to present an epidemiological assessment of leukemia in the population of Kazakhstan during 2003-2012. This descriptive and retrospective study was based on data obtained from all oncological organizations of the whole country. Age standardized incidence rates per 100,000 population for leukemia were calculated. Totally, 6,741 new cases of leukemia were registered in Kazakhstan during the 10 year period. The mean age of patients with leukemia was 48.5. The ASRs for leukemia among men and women were 5.3 and 3.6, respectively (p<0.001). In conclusion, our results showed a high incidence rate of leukemia in Kazakhstan, especially in the north of the country. The incidence of leukemia was significantly higher in males and increased with age. Determining and controlling important risk factors of leukemia may lead to decrease in its burden.

show abstract

Section: Discussionsupporting

confidence: 80%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012

Igissinov

Kulmirzayeva²,

Moore³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…In a study which was done by Rajabli et al from 2004Rajabli et al from -2009 in Golestan province, standardized incidence rate for leukemia among men and women were respectively 10.4 and 7.8 (per 100000 population), respectively. Similar age standardized incidence rate for multiple myeloma among men and women were obtained equal to 2.1 and 2 (per 100000 populations) which is higher than country and whole world (Rajabli et al, 2013).…”

Section: Discussionsupporting

confidence: 69%

“…Similar studies in USA concerning blood cancer in Europe and USA in 2005 showed that overall incidences for hematopoietic malignancies have been raised along western countries and AML incidence had slow decrease or stable trend in the most European countries but it has been surged in Wales and England about 70% from 1971 for both sexes (Rodriguez-Abreu et al, 2007). Also researches have shown that different blood cancer incidence are higher among men (than women) which is comparable in the countries including Iran, Kazakhstan, Croatia, European union and United states (Coebergh et al, 2006;Tahmasebi et al, 2006;Rodriguez-Abreu et al, 2007;Hejazi et al, 2010;Sant et al, 2010;Dastgiri et al, 2011;Farahmand et al, 2011;Modak et al, 2011;Smith et al, 2011;Dores et al, 2012;Novak et al, 2012;Rajabli et al, 2013) and higher incidence among men may be attributed to genetically or environmental factors (Rajabli et al, 2013;Igissinov et al, 2014).…”

Section: Discussionmentioning

confidence: 98%

Leukemia in Iran: Epidemiology and Morphology Trends

Koohi

Salehiniya²,

Shamlou³

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Leukemia accounts for 8% of total cancer cases and involves all age groups with different prevalence and incidence rates in Iran and the entire world and causes a significant death toll and heavy expenses for diagnosis and treatment processes. This study was done to evaluate epidemiology and morphology of blood Statistical analysis for incidence time trends and morphology change percentage was performed with joinpoint regression analysis using the software Joinpoint Regression Program. Results: During the studied years a total of 18,353 hematopoietic and reticuloendothelial system cancers were recorded. Chi square test showed significant difference between sex and morphological types of blood cancer (P-value<0.001). Joinpoint analysis showed a significant increasing trend for the adjusted standard incidence rate (ASIR) for both sexes (P-value<0.05). Annual percent changes (APC) for women and men were 18.7 and 19.9, respectively. The most common morphological blood cancers were ALL, ALM, MM and CLL which accounted for 60% of total hematopoietic system cancers. Joinpoint analyze showed a significant decreasing trend for ALM in both sexes (P-value<0.05). Conclusions: Hematopoietic system cancers in Iran demonstrate an increasing trend for incidence rate and decreasing trend for ALL, ALM and CLL morphology.

show abstract

Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study

Tsang

Ghazawi

et al. 2019

Cancer

View full text Add to dashboard Cite

Background Multiple myeloma (MM) is a malignancy of mature plasma cells. Environmental risk factors identified for this malignancy, among others, include farming and exposure to pesticides. Methods Using 3 independent population‐based databases (the Canadian Cancer Registry, le Registre Québécois du Cancer, and Canadian Vital Statistics), this study analyzed patients’ clinical characteristics and the incidence, mortality, and geographic distribution of MM cases in Canada during 1992‐2015. Results In total, ~32,065 patients were identified, and 53.7% were male. The mean age at the time of diagnosis was 70 ± 12.1 years. The average incidence rate in Canada was 54.29 cases per million individuals per year, and linear regression modeling showed a steady rise in the annual rate of 0.96 cases per million individuals per year. At the provincial level, Quebec and Ontario had significantly higher incidence rates than the rest of Canada. An analysis of individual municipalities and postal codes showed lower incidence rates in large metropolitan areas and in high‐latitude regions of the country, whereas high incidence rates were observed in smaller municipalities and rural areas. Land use analysis demonstrated increased density of crop farms and agricultural industries in high‐incidence areas. A comparison with the available data from 2011‐2015 showed several consistent trends at provincial, municipal, and regional levels. Conclusions These results provide a comprehensive analysis of the MM burden in Canada. Large metropolitan cities as well as high‐latitude regions were associated with lower MM incidence. Higher incidence rates were noted in smaller cities and rural areas and were associated with increased density of agricultural facilities.

show abstract

Epidemiology of Leukemia and Multiple Myeloma in Golestan, Iran

Cited by 33 publications

References 10 publications

Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012

Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012

Leukemia in Iran: Epidemiology and Morphology Trends

Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study

Contact Info

Product

Resources

About